Загрузка...
Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors
Buprenorphine is a mixed opioid receptor agonist-antagonist used clinically for maintenance therapy in opiate addicts and pain management. Dose-response curves for buprenorphine-induced antinociception display ceiling effects or are bell shaped, which have been attributed to the partial agonist acti...
Сохранить в:
| Опубликовано в: : | J Neurosci |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society for Neuroscience
2003
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741014/ https://ncbi.nlm.nih.gov/pubmed/14614092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.23-32-10331.2003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|